The Korea probiotic supplement industry is projected to expand at a CAGR of 11.6% through 2033. The demand for probiotic supplement in Korea is predicted to overgrow, reaching USD 241.03 million in 2023.
Growing public awareness of the significance of gut health, as well as increased demand for functional foods and dietary supplement, have all contributed to the industry expansion of probiotic supplement in Korea. The industry size of probiotic supplement in Korea is likely to be worth USD 722.70 million by 2033.
Key Highlights
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2023) | USD 241.03 million |
Anticipated Forecast Value (2033) | USD 722.70 million |
Estimated Growth (2023 to 2033) | 11.6% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Details |
---|---|
Bacteria Type | Lactobacillus |
Industry Share in 2023 | 36.3% |
Attributes | Details |
---|---|
End User | Women |
Industry Share in 2023 | 42.5% |
Industry players have employed various growth strategies to gain a competitive advantage, including capacity expansions, mergers and acquisitions, enhancing their online presence, and introducing new products. Some of the top Korean probiotic supplement firms include Cell Biotech, AceBiome, Amorepacific, Chong Dun Kang, Esther Formula, CJ Cheiljedang, and IIdong Pharmaceutical.
Innovations and creative approaches have benefited the probiotic supplement sector in Korea. Several product introductions in recent years have expanded the industry's client base while intensifying competition within the sector.
Recent Development in the Probiotic Supplement Industry in Korea
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attribute | Details |
---|---|
Estimated Valuation (2023) | USD 241.03 million |
Projected Valuation (2033) | USD 722.70 million |
Anticipated CAGR (2023 to 2033) | 11.6% CAGR |
Historical Analysis of Probiotic Supplement in Korea | 2018 to 2022 |
Demand Forecast for Probiotic Supplement in Korea | 2023 to 2033 |
Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
Report Coverage | Industry Size, Industry Trends, Key Insights for Probiotic Supplement Adoption in Korea, Insights on Global Players and Leading Industry Strategy in Korea, Ecosystem Analysis of Local and Regional Industry. |
Key Companies Profiled | Cell Biotech; AceBiome; Amorepacific; Chong Dun Kang; Esther Formula; CJ Cheiljedang; IIdong Pharmaceutical |
The anticipated CAGR for the Korea probiotic supplement industry through 2033 is 11.6%.
Demand for probiotic supplement in Korea is likely to surpass USD 722.70 million by 2033.
In 2023, the industry size for probiotic supplement in Korea is valued at USD 241.03 million.
Lactobacillus are highly preferred in Korea, with an industry share of 36.3%.
In Korea, women consumers dominates the probiotic supplement industry with 42.5% industry share.
1. Executive Summary 2. Market Overview 3. Market Background 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Bacteria 5.1. Lactobacillus 5.2. Streptococcus 5.3. Bifid bacterium 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form 6.1. Tablet 6.2. Capsules 6.3. Liquid 6.4. Powder Premixes 6.5. Gummies/Chewable 6.6. Lozenges 6.7. Liquid & Gels 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Function 7.1. Immunity & Digestive Health 7.2. Urogenital Health 7.3. Vaginal Health 7.4. Urinary Tract Infections 7.5. Pregnancy 7.6. Weight Management 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 8.1. Hypermarket/ Supermarket 8.2. Specialty Stores 8.3. E-Commerce 8.4. Pharmacy Stores 9. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By End User 9.1. Women 9.2. Seniors 9.3. Kids 10. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. South Gyeongsang 10.2. North Jeolla 10.3. South Jeolla 10.4. Jeju 10.5. Rest of Korea 11. South Gyeongsang Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 12. North Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 13. South Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 14. Jeju Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 15. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 16. Market Structure Analysis 17. Competition Analysis 17.1. MEDIOGEN 17.2. ESTHER FORMULA 17.3. Jarrow Formulas 17.4. NOVA Probiotics 17.5. Lifeway Foods 17.6. Natural Factors 17.7. Pharma Care Laboratories 17.8. Total Nutrition 17.9. Church & Dwight 17.10. Goerlich Pharma 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Food and Beverage Insights
View Reports